{
    "organizations": [],
    "uuid": "ada1b68b524443ca105e3a585230e92bf552b1c7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amneal-announces-fda-approval-and/brief-amneal-announces-fda-approval-and-launch-of-generic-welchol-tablets-625-mg-idUSASC0A2SY",
    "ord_in_thread": 0,
    "title": "BRIEF-Amneal Announces FDA Approval And Launch Of Generic Welchol® (Colesevelam Hcl) Tablets, 625 Mg",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Amneal Pharmaceuticals Inc:\n* AMNEAL ANNOUNCES FDA APPROVAL AND LAUNCH OF GENERIC WELCHOL® (COLESEVELAM HCL) TABLETS, 625 MG\n* AMNEAL PHARMACEUTICALS INC - INITIATED COMMERCIALIZATION ACTIVITIES FOR WELCHOL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-17T21:43:00.000+03:00",
    "crawled": "2018-05-18T19:33:36.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "amneal",
        "pharmaceutical",
        "inc",
        "amneal",
        "announces",
        "fda",
        "approval",
        "launch",
        "generic",
        "colesevelam",
        "hcl",
        "tablet",
        "mg",
        "amneal",
        "pharmaceutical",
        "inc",
        "initiated",
        "commercialization",
        "activity",
        "welchol",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}